By Scientia Professor John Martin Kaldor

Journal articles

Stafford JA; Post JJ; Kaldor JM; Pan Y; Haber P; Lloyd AR; Dolan K, 2004, 'Risk factors for hepatitis C infection and perception of antibody status among male prison inmates in the Hepatitis C Incidence and Transmission in Prisons Study Cohort, Australia', Journal of Urban Health - Bulletin of the New York Academy of Medicine, 81, pp. 448 - 452, http://dx.doi.org/10.1093/jurban/jth129

Hughes A; Armstrong BK; Vajdic CM; Turner J; Grulich AE; Fritschi L; Milliken ST; Kaldor JM; Benke G; Kricker A, 2004, 'Sun exposure may protect against non-Hodgkin lymphoma: A case-controlstudy', International Journal of Cancer, 112, pp. 865 - 871

Robotin M; Copland J; Tallis G; Coleman D; Giele C; Carter L; Spencer J; Kaldor JM; Dore GJ, 2004, 'Surveillance for newly acquired hepatitis C in Australia', Journal of Gastroenterology and Hepatology, 19, pp. 283 - 288

Turner J; Hughes AM; Kricker A; Milliken ST; Grulich AE; Kaldor JM; Armstrong BK, 2004, 'Use of the WHO lymphoma classification in a population-based epidemiological study', Annals of Oncology, 15, pp. 631 - 637, http://www.sciencedirect.com/science/article/B6WVB-4C7NNW9-19W/2/fe877418c0bb9f98703ef22c1660fe82

Graves N; Walker DW; McDonald AM; Kaldor JM; Ziegler JB, 2004, 'Would universal antenatal screening for HIV infection be cost-effective in a setting of very low prevelance? Modelling the data for Australia', Journal of Infectious Diseases, 190, pp. 166 - 175

Porter K; Law M; Dabis F; Thiebaut R; Chêne G; Lawson-Ayayi S; Meyer L; Boufassa F; Hamouda O; Fischer K; Pezzotti P; Rezza G; Touloumi G; Hatzakis A; Karafoulidou A; Katsarou O; Brettle R; Del Amo J; del Romero J; van Asten L; van Benthem B; Prins M; Coutinho R; Kirk O; Pedersen C; Hernández Aguado I; Pérez-Hoyos S; Eskild A; Bruun JN; Sannes M; Sabin C; Lee C; Johnson AM; Phillips AN; Babiker A; Darbyshire JH; Gill N; Porter K; Francioli P; Vanhems P; Egger M; Rickenbach M; Cooper D; Kaldor J; Ashton L; Vizzard J; Muga R; Day NE; De Angelis D, 2003, 'Estimating the effect of antiretroviral treatment during HIV seroconversion: Impact of confounding in observational data', HIV Medicine, 4, pp. 332 - 337, http://dx.doi.org/10.1046/j.1468-1293.2003.00168.x

Sullivan EA; Abel M; Tabrizi S; Garland SM; Grice A; Poumerol G; Taleo H; Chen S; Kaun K; O'Leary M; Kaldor J, 2003, 'Prevalence of sexually transmitted infections among antenatal women in Vanuatu, 1999-2000', Sexually Transmitted Diseases, 30, pp. 362 - 366, http://dx.doi.org/10.1097/00007435-200304000-00017

Dore GJ; MacDonald M; Law MG; Kaldor JM, 2003, 'Epidemiology of hepatitis C virus infection in Australia.', Australian family physician, 32, pp. 796 - 798

Hiransuthikul N; Hanvanich M; Dore GJ; Mokkhawes T; Li Y; Perriens J; Kaldor JM, 2003, 'Factors associated with tuberculin skin test reactivity among HIV-infected people in Bangkok', Southeast Asian Journal of Tropical Medicine and Public Health, 34, pp. 804 - 809

MICALLEF J; JAUNCEY M; AMIN J; RAWLINSON W; GILMOUR S; VANBEEK I; KALDOR J; WHITE P; DORE G, 2003, '229 Hepatitis C virus reinfection within a cohort of injecting drug users', Hepatology, 38, pp. 266 - 266, http://dx.doi.org/10.1016/s0270-9139(03)80272-0

Blumer C; Roche P; Spencer J; Lin M; Milton A; Bunn C; Gidding HF; Kaldor JM; Kirk M; Hall R; Della-Porta T; Leader R; Wright P, 2003, 'Australia's notifiable diseases status, 2001: annual report of the National Notifiable Diseases Surveillance System', Annual report of the Australian Meningococcal Surveillance Programme, 2007--Amended, 27, pp. 1 - 78

Butler TG; Levy MH; Dolan K; Kaldor JM, 2003, 'Drug use and its correlates in an Australian prison population', Addiction Research and Theory, 11, pp. 89 - 101

MacDonald MA; Law MG; Kaldor JM; Hales J; Dore GJ, 2003, 'Effectiveness of needle and syringe programmes for preventing HIV transmission', International Journal of Drug Policy, 14, pp. 353 - 357

Keoshkerian E; Ashton LJ; Smith DG; Ziegler JB; Kaldor JM; Cooper DA; Stewart GJ; Ffrench R, 2003, 'Effector HIV-specific cytotoxic T lymphocyte activity in HIV non-progressors correlates with viral replication and progression', Journal of Medical Virology, 71, pp. 483 - 491

Dore GJ; Law MG; MacDonald MA; Kaldor JM, 2003, 'Epidemiology of hepatitis C virus infection in Australia', Journal of Clinical Virology, 26, pp. 171 - 184

O Sullivan BG; Levy MH; Dolan K; Post JJ; Barton SG; Dwyer D; Kaldor JM; Grulich AE, 2003, 'Hepatitis C transmission and HIV post-exposure prophylaxis after needle-and syringe-sharing in Australian prisons', Medical Journal of Australia, 178, pp. 546 - 549

Miller J; Carr AD; Emery S; Law MG; Mallal SS; Baker D; Smith DG; Kaldor JM; Cooper DA, 2003, 'HIV lipodystrophy: prevalence, severity and correlates of risk in Australia', HIV Medicine, 4, pp. 293 - 301

Kaldor JM; McDonald AM, 2003, 'HIV/AIDS surveillance systems in Australia', Journal of Acquired Immune Deficiency Syndrome, 32, pp. 18 - 23

French MA; Herring BL; Kaldor JM; Sayer DC; Furner V; Chaneet CC; Dwyer DE, 2003, 'Intrafamilial transmission of HIV 1 infection from individuals with unrecognised HIV 1 Infection', AIDS, 17, pp. 1977 - 1981

McDonald AM; Li Y; Dore GJ; Ree H; Kaldor JM, 2003, 'Late HIV presentation among AIDS cases in Australia, 1992-2001', Australian and New Zealand Journal of Public Health, 27, pp. 608 - 613

Dore GJ; McDonald AM; Li Y; Kaldor JM; Brew BJ, 2003, 'Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy', AIDS, 17, pp. 1539 - 1545

Law MG; Dore GJ; Bath N; Thompson S; Crofts N; Dolan K; Giles W; Gow P; Kaldor JM; Loveday S; Powell E; Spencer J; Wodak AD, 2003, 'Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001', International Journal of Epidemiology, 32, pp. 717 - 724

Dore GJ; Freeman A; Law MG; Kaldor JM, 2003, 'Natural history models for hepatitis C-related liver disease: different disease progression parameters for different settings', Antiviral Therapy, 8, pp. 365 - 372

Kaldor J, 2003, 'Obituary-Margaret MacDonald 1956–2003', International Journal of Drug Policy, 14, pp. 349 - 349, http://dx.doi.org/10.1016/j.drugpo.2003.10.002

Freeman A; Law MG; Kaldor JM; Dore GJ, 2003, 'Predicting progression to cirrhosis in chronic hepatitis C virus infection', Journal of Viral Hepatitis, 10, pp. 285 - 293

Spencer J; Tibbits D; Tippet C; Mead C; Kaldor JM; Dore GJ, 2003, 'Review of antenatal testing policies and pratice for HIV and hepatitis C infection', Australian and New Zealand Journal of Public Health, 27, pp. 614 - 619

Kippax SC; Slavin SF; Ellard JM; Hendry O; Richters J; Grulich AE; Kaldor JM, 2003, 'Seroconversion in context', AIDS Care - Psychological and Socio - Medical Aspects of AIDS/HIV, 15, pp. 839 - 852

Murray JM; Law MG; Gao Z; Kaldor JM, 2003, 'The impact of behavioural changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users', International Journal of Epidemiology, 32, pp. 708 - 714, http://ije.oxfordjournals.org/content/32/5/708.abstract

Kimber J; MacDonald MA; Van Beek IA; Kaldor JM; Weatherburn D; Lapsley HM; Mattick RP, 2003, 'The Sydney Medically Injecting Centre : Client Characteristics and Predictors of Frequent Attendance Druing the First 12 Months of Operation', Journal of Drug Issues, 33, pp. 639 - 648

Collins S; Boyd A; Lee JS; Lewis V; Fletcher A; McLean CA; Law M; Kaldor J; Smith MJ; Masters CL, 2002, 'Creutzfeldt-Jakob disease in Australia 1970-1999', Neurology, 59, pp. 1365 - 1371, http://dx.doi.org/10.1212/01.WNL.0000031793.11602.8C

Dore GJ; Freeman AJ; Kaldor JM; Post JJ; Harvey CE; Ffrench RA; Lloyd AR; Mehta SH; Cox AL; Strathdee SA; Vlahov D; Thomas DL, 2002, 'Immunity against hepatitis C virus infection [2] (multiple letters)', Lancet, 360, pp. 1019 - 1020, http://dx.doi.org/10.1016/s0140-6736(02)11102-0

Lin M; Roche P; Spencer J; Milton A; Wright P; Witteveen D; Leader R; Merianos A; Bunn C; Gidding H; Kaldor J; Kirk M; Hall R; Della-Porta T, 2002, 'Australia's notifiable diseases status, 2000. Annual report of the National Notifiable Diseases Surveillance System.', Communicable diseases intelligence, 26, pp. 118 - 203

Babiker A; Darbyshire J; Pezzotti P; Porter K; Rezza G; Walker AS; Beral V; Coutinho R; Del Amo J; Gill N; Lee C; Meyer L; Rezza G; Tyrer F; Dabis F; Thiebaut R; Lawson-Aye S; Meyer L; Boufassa F; Hamouda O; Fischer K; Touloumi G; Hatzakis A; Karafoulidou A; Katsarou O; Brettle R; del Romero J; Prins M; Coutinho RA; van Benthem B; Kirk O; Pedersen C; Hernández Aguado I; Pérez-Hoyos S; Eskild A; Bruun JN; Sannes M; Sabin C; Johnson AM; Phillips AN; Darbyshire JH; Francioli P; Vanhems P; Egger M; Riekenbach M; Cooper D; Kaldor J; Ashton L; Vissard J; Muga R; Day NE; De Angelis D, 2002, 'Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks', International Journal of Epidemiology, 31, pp. 951 - 958, http://dx.doi.org/10.1093/ije/31.5.951

Dore GJ; Freeman A; Kaldor JM, 2002, '. Immunity against hepatitis C virus infection', Lancet, 360, pp. 1019 - 1020

Miller J; Brown DA; Amin J; Kent-Hughes J; Law MG; Cooper DA; Carr AD, 2002, 'A randomised, double-blind study of gemfibrozil for the treatment of protease inhibitor-associated hypertriglyceridaemia', AIDS, 16, pp. 2195 - 2200

Kaldor JM, 2002, 'Biomedical Responses to the AIDS epidemic', Australasian Science, pp. 18 - 20

Collins SP; Boyd A; Fletcher A; Kaldor JM; Hill A; Farish S; Mclean C; Ansari Z; Smith MJ; Masters CL, 2002, 'Creutzfeldt-Jakob disease cluster in an Australian rural city', Annals of Neurology, 52, pp. 115 - 118

Li Y; Law MG; McDonald AM; Kaldor JM; Grulich AE, 2002, 'Estimation of risk of cancers before occurrence of acquired immunodeficiency syndrome in persons infected with human immunodeficiency virus', American Journal of Epidemiology, 155, pp. 153 - 158

Grulich AE; Kaldor JM, 2002, 'Evidence of success in HIV prevention in Africa', Lancet, 360, pp. 3 - 4, http://dx.doi.org/10.1016/S0140-6736(02)09359-5

Danta M; Dore GJ; Hennessy L; Li Y; Vickers CR; Harley H; Ngu M; Reed W; Desmond PV; Sievert W; Farrell G; Kaldor JM; Batey RG, 2002, 'Factors associated with severity of hepatic fibrosis in people with chronic hepatitis C infection', Medical Journal of Australia, 177, pp. 240 - 245

Ashton LJ; Stewart GJ; Biti RA; Law MG; Cooper DA; Kaldor JM, 2002, 'Heterozygosity for CCR5-∆32 but not CCR2b-64l protects against certain intracellular pathogens', HIV Medicine, 3, pp. 91 - 96

Dore GJ; Li Y; McDonald AM; Ree H; Kaldor JM, 2002, 'Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 29, pp. 388 - 395

Dore GJ; Freeman A; Law MG; Kaldor JM, 2002, 'Is severe liver disease a common outcome for people with chronic hepatitis C?', Journal of Gastroenterology and Hepatology, 17, pp. 423 - 430

Spencer J; Dore GJ; Robotin M; Correll PK; Kaldor JM, 2002, 'Outcomes from the first two years of the Australian Hepatitis surveillance strategy', Annual report of the Australian Meningococcal Surveillance Programme, 2007--Amended, 26, pp. 14 - 22

Jin F; Prestage G; Law MG; Kippax SC; Van De Ven PG; Rawstorne PR; Kaldor JM; Grulich AE, 2002, 'Predictors of recent HIV testing in homosexual men in Australia', HIV Medicine, 3, pp. 271 - 276

Grulich AE; Li Y; McDonald AM; Correll PK; Law MG; Kaldor JM, 2002, 'Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis', AIDS, 16, pp. 1155 - 1161

Butler T; Donovan BJ; Levy MH; Kaldor JM; Butler , 2002, 'Sex behind the prison walls', Australian and New Zealand Journal of Public Health, 26, pp. 390 - 390

Law MG; Dore GJ; Kaldor JM, 2001, 'Projecting severe sequelae of injection-related hepatitis C virus epidemic in UK by SM Bird, DJ Goldberg and SJ Hutchinson', Journal of Epidemiology and Biostatistics, 6, pp. 279 - 281, http://dx.doi.org/10.1080/135952201317080689

Babiker A; Darbyshire J; Pezzotti P; Porter K; Rezza G; Walker S; Beral V; Coutinho R; Del Amo J; Gill N; Lee C; Meyer L; Tyrer F; Dabis F; Thiebaut R; Lawson-Ayayi S; Boufassa F; Hamouda O; Lorenzo JI; Touloumi G; Hatzakis A; Karafoulidou A; Katsarou O; Brettle R; Del Romero J; Prins M; Coutinho RA; Van Benthem B; Kirk O; Pedersen C; Hernández Aguado I; Pérez-Hoyos S; Eskild A; Bruun JN; Sannes M; Sabin C; Johnson AM; Phillips AN; Darbyshire JH; Gill N; Francioli P; Vanhems P; Egger M; Rickenbach M; Cooper D; Kaldor J; Vizzard J; Tusell JM; Ruiz I; Cayla JA; Garcia de Olalla P; Day NE; De Angelis D, 2001, 'Is the time from HIV seroconversion a determinant of the risk of AIDS after adjustment for updated CD4 cell counts?', Journal of Acquired Immune Deficiency Syndromes, 28, pp. 158 - 165, http://dx.doi.org/10.1097/00126334-200110010-00008

Grulich AE; Hendry O; Clark E; Kippax S; Kaldor JM, 2001, 'Circumcision and male-to-male sexual transmission of HIV', AIDS, 15, pp. 1188 - 1189, http://dx.doi.org/10.1097/00002030-200106150-00020

Back to profile page